Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Puzzle Medical Devices

Puzzle Medical Device is a developer of a low-risk heart pump intended to cater to the needs of patients suffering from advanced heart failure
2018
Nov-50
11-50
Quebec, Canada
  • Cardiac (Heart Valves)
  • Drug Delivery and Devices
  • Medical Imaging and Visualization Technology
  • Services (Patient care)

Innovation

Industry Problem

Advanced heart-failure patients may need circulatory support, but conventional pumps can require large access vessels and complex procedures.

R&D Focus

Percutaneous modular heart pumps and mechanical circulatory support.

Innovative Solution

ModulHeart uses several small pumps placed through minimally invasive access to reduce cardiac workload and support organ perfusion.

Solution Effectiveness

In a four-patient first-in-human study, the device was deployed, activated and removed successfully with no procedural or device-related complications; cardiac and kidney-function measures improved.

Investment Funding

Last Funding Stage

Series B

Last Funding Amount

$50M

Startup Stage

Growth Stage

Lead Investors

Accelo (Denver), AG Collective Capital, Ajax Health, BDC Capital, Cordis

People

Founders

CEO

About

Puzzle Medical Device is a developer of a low-risk heart pump intended to cater to the needs of patients suffering from advanced heart failure

Products

Product

ModulHeart percutaneous mechanical circulatory support system.

Star Product

ModulHeart, because it is the company’s lead device and has completed first-in-human evaluation.

Demo Product or Complete Product?

Clinical-development stage; first-in-human study completed and further clinical work is planned.

Future Plan

Market Expansion

Funding supports a larger clinical program and future regulatory submissions in North America and Europe.

Investment Funding

Announced a C$43 million financing round to support clinical development; an earlier seed round funded the first-in-human study.

Awards and Recognitions

Certifications

US FDA Breakthrough Device designation.

M&A and Collabs

Collab

Clinical investigators in Canada and Europe: first-in-human and follow-on clinical studies.

Collab

Academic cardiovascular researchers: organ-perfusion and device-performance studies.

Something missing or incorrect on this page? Help us enrich this information